CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0998
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Head and Neck Cancers

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Novel Chemoradiotherapy Regimens Incorporating Targeted Therapies in Locally Advanced Head and Neck Cancers

2012English

Head and Neck Cancers

2019English

Public Awareness of Head and Neck Cancers

JAMA Otolaryngology - Head and Neck Surgery
MedicineOtorhinolaryngologySurgery
2014English

Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional P53

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Intraoperative Radiation Therapy in Head and Neck Cancers

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Use of PET in Head and Neck Cancers

Turk Otolarengoloji Arsivi/Turkish Archives of Otolaryngology
2015English

Response Rate to Neo-Adjuvant Chemotherapy Oh Head and Neck Cancers.

Japanese jornal of Head and Neck Cancer
1991English

Inhibition of EphB4-ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy